BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2879579)

  • 1. Inosine monophosphate dehydrogenase and myeloid cell maturation.
    Knight RD; Mangum J; Lucas DL; Cooney DA; Khan EC; Wright DG
    Blood; 1987 Feb; 69(2):634-9. PubMed ID: 2879579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for guanine ribonucleotides in the regulation of myeloid cell maturation.
    Wright DG
    Blood; 1987 Jan; 69(1):334-7. PubMed ID: 2878694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purine metabolism in myeloid precursor cells during maturation. Studies with the HL-60 cell line.
    Lucas DL; Webster HK; Wright DG
    J Clin Invest; 1983 Dec; 72(6):1889-900. PubMed ID: 6139386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of IMP dehydrogenase activity and guanylate metabolism by tiazofurin (2-beta-D-ribofuranosylthiazole-4-carboxamide).
    Lui MS; Faderan MA; Liepnieks JJ; Natsumeda Y; Olah E; Jayaram HN; Weber G
    J Biol Chem; 1984 Apr; 259(8):5078-82. PubMed ID: 6143752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in glycoprotein synthesis and guanosine triphosphate levels associated with the differentiation of HL-60 leukemia cells produced by inhibitors of inosine 5'-phosphate dehydrogenase.
    Sokoloski JA; Blair OC; Sartorelli AC
    Cancer Res; 1986 May; 46(5):2314-9. PubMed ID: 2870796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme-pattern-targeted chemotherapy with tiazofurin and allopurinol in human leukemia.
    Weber G; Jayaram HN; Lapis E; Natsumeda Y; Yamada Y; Yamaji Y; Tricot GJ; Hoffman R
    Adv Enzyme Regul; 1988; 27():405-33. PubMed ID: 2907968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inosine monophosphate dehydrogenase activity in acute leukaemia.
    Price GM; Hoffbrand AV; Taheri MR; Evans JP
    Leuk Res; 1987; 11(6):525-8. PubMed ID: 2885446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemically directed therapy of leukemia with tiazofurin, a selective blocker of inosine 5'-phosphate dehydrogenase activity.
    Tricot GJ; Jayaram HN; Lapis E; Natsumeda Y; Nichols CR; Kneebone P; Heerema N; Weber G; Hoffman R
    Cancer Res; 1989 Jul; 49(13):3696-701. PubMed ID: 2567208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of tiazofurin on guanine nucleotide binding regulatory proteins in HL-60 cells.
    Kharbanda SM; Sherman ML; Kufe DW
    Blood; 1990 Feb; 75(3):583-8. PubMed ID: 1967538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of IMP dehydrogenase in differentiating HL-60 cells.
    Collart FR; Huberman E
    Blood; 1990 Feb; 75(3):570-6. PubMed ID: 1967537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consequences of IMP dehydrogenase inhibition, and its relationship to cancer and apoptosis.
    Jayaram HN; Cooney DA; Grusch M; Krupitza G
    Curr Med Chem; 1999 Jul; 6(7):561-74. PubMed ID: 10390601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induced maturation of the human promyelocytic leukemia cell line, HL-60, by 2-beta-D-ribofuranosylselenazole-4-carboxamide.
    Lucas DL; Robins RK; Knight RD; Wright DG
    Biochem Biophys Res Commun; 1983 Sep; 115(3):971-80. PubMed ID: 6138039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical differences among four inosinate dehydrogenase inhibitors, mycophenolic acid, ribavirin, tiazofurin, and selenazofurin, studied in mouse lymphoma cell culture.
    Lee HJ; Pawlak K; Nguyen BT; Robins RK; Sadée W
    Cancer Res; 1985 Nov; 45(11 Pt 1):5512-20. PubMed ID: 2865005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of 2-amino-1,3,4-thiadiazole on ribonucleotide pools of leukemia L1210 cells.
    Nelson JA; Rose LM; Bennett LL
    Cancer Res; 1976 Apr; 36(4):1375-8. PubMed ID: 130972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of tiazofurin on protooncogene expression during HL-60 cell differentiation.
    Kharbanda SM; Sherman ML; Spriggs DR; Kufe DW
    Cancer Res; 1988 Nov; 48(21):5965-8. PubMed ID: 2901907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitive radiochemical assay for inosine 5'-monophosphate dehydrogenase and determination of activity in murine tumor and tissue extracts.
    Proffitt RT; Pathak VK; Villacorte DG; Presant CA
    Cancer Res; 1983 Apr; 43(4):1620-3. PubMed ID: 6131740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Quantitative histochemical study of the reaction kinetics to inosine-5-monophosphate dehydrogenase and 5'-nucleotidase in cryostat sections of rat liver].
    Grushetskaia NV; Prianishnikov VA
    Tsitologiia; 1983 Jul; 25(7):805-10. PubMed ID: 6137890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and molecular impact of inhibition of IMP dehydrogenase activity by tiazofurin.
    Weber G; Yamaji Y; Olah E; Natsumeda Y; Jayaram HN; Lapis E; Zhen WN; Prajda N; Hoffman R; Tricot GJ
    Adv Enzyme Regul; 1989; 28():335-56. PubMed ID: 2576178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on inosine monophosphate dehydrogenase. Steady state kinetics.
    Heyde E; Nagabhushanam A; Vonarx M; Morrison JF
    Biochim Biophys Acta; 1976 May; 429(3):645-60. PubMed ID: 178371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IMP dehydrogenase inhibitors as immunomodulators.
    Mitchell BS; Dayton JS; Turka LA; Thompson CB
    Ann N Y Acad Sci; 1993 Jun; 685():217-24. PubMed ID: 8103312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.